Prosecution Insights
Last updated: April 19, 2026

BLISS BIOPHARMACEUTICAL (HANGZHOU) CO., LTD.

1 pending office actions

Portfolio Summary

1
Total Pending OAs
0
Final Rejections
1
Non-Final OAs

Pending Office Actions

App #TitleExaminerArt UnitStatusFiled
18253703 ANTI-CD73 ANTIBODY, ANTIBODY-DRUG CONJUGATE, AND USE THEREOF GODDARD, LAURA B 1642 Non-Final OA May 19, 2023

Managing BLISS BIOPHARMACEUTICAL (HANGZHOU) CO., LTD.'s Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month